Pharmacology · patient case with 4 questions

Chest Pain During the Appointment

Patient: 64-year-old female

Chief Complaint: “My mouth is hurting on the upper right.”

Background: Hyperlipidemia and hypertension, both reportedly well controlled. Non-smoker. No prior cardiac events.

Medications: Simvastatin 40 mg daily · Carvedilol 12.5 mg twice daily · Aspirin 81 mg daily

Vital Signs: On seating: BP 138/84 mmHg · HR 68 bpm · RR 16 · T 98.4°F

Findings: During the examination she develops crushing substernal chest pain radiating into the left arm, with diaphoresis. Emergency medical services are activated, oxygen is delivered, and a sublingual nitroglycerin tablet is administered. Her panoramic radiograph, taken earlier, incidentally shows diffusely narrowed pulp chambers and canals in multiple posterior teeth.

Question 1

What is the mechanism of action of simvastatin?

  1. Inhibits intestinal cholesterol absorption at the brush border
  2. Inhibits HMG-CoA reductase
  3. Activates lipoprotein lipase
  4. Binds bile acids in the intestinal lumen
Show answer and explanation

Correct answer: B. Inhibits HMG-CoA reductase

  • A. Incorrect. That is ezetimibe, which blocks the NPC1L1 sterol transporter in the intestinal brush border.
  • B. Correct. Statins competitively inhibit HMG-CoA reductase, the rate-limiting enzyme of hepatic cholesterol synthesis. Falling intracellular cholesterol upregulates hepatic LDL receptors, which clears LDL from the circulation.
  • C. Incorrect. Lipoprotein lipase activation is the mechanism of the fibrates such as gemfibrozil and fenofibrate, which are used primarily to lower triglycerides.
  • D. Incorrect. That describes the bile acid sequestrants — cholestyramine, colesevelam — which interrupt enterohepatic recirculation of bile acids.

Permanent page for this question

Question 2

What is the mechanism of action of the sublingual nitroglycerin she has just been given?

  1. Releases nitric oxide, which activates guanylyl cyclase and raises cGMP
  2. Inhibits cyclooxygenase and reduces prostaglandin synthesis
  3. Blocks L-type calcium channels in vascular smooth muscle
  4. Increases cAMP through beta-1 adrenergic stimulation
Show answer and explanation

Correct answer: A. Releases nitric oxide, which activates guanylyl cyclase and raises cGMP

  • A. Correct. Nitroglycerin is metabolized to nitric oxide, which activates soluble guanylyl cyclase. The resulting rise in cGMP dephosphorylates myosin light chains and relaxes vascular smooth muscle. Venodilation predominates, reducing preload and therefore myocardial oxygen demand.
  • B. Incorrect. COX inhibition is the mechanism of the aspirin she already takes. Aspirin is critical in acute coronary syndrome for its antiplatelet effect, but that is not how nitroglycerin works.
  • C. Incorrect. Calcium channel blockade describes amlodipine, nifedipine, and diltiazem. These also treat angina, but through a different pathway.
  • D. Incorrect. Beta-1 stimulation with rising cAMP describes dobutamine or epinephrine at the cardiac receptor. It increases oxygen demand, the opposite of what is needed in angina.

Note: Contraindication worth knowing: nitroglycerin must not be given within 24–48 hours of a phosphodiesterase-5 inhibitor such as sildenafil or tadalafil. The combination causes profound, refractory hypotension.

Permanent page for this question

Question 3

Which statement best describes how carvedilol reduces cardiac workload?

  1. It selectively blocks beta-2 receptors in bronchial smooth muscle
  2. It blocks the angiotensin II type 1 receptor
  3. It blocks beta-1, beta-2, and alpha-1 receptors, lowering heart rate, contractility, and afterload
  4. It inhibits angiotensin-converting enzyme
Show answer and explanation

Correct answer: C. It blocks beta-1, beta-2, and alpha-1 receptors, lowering heart rate, contractility, and afterload

  • A. Incorrect. Selective beta-2 blockade has no therapeutic use and would provoke bronchospasm. Beta-2 agonism, not antagonism, is what albuterol does.
  • B. Incorrect. Angiotensin II receptor blockade describes losartan and valsartan — the drugs with the -sartan suffix.
  • C. Correct. Carvedilol is a third-generation, non-selective beta blocker with additional alpha-1 antagonism. Beta blockade lowers heart rate and contractility, reducing oxygen demand, while alpha-1 blockade produces peripheral vasodilation that lowers afterload.
  • D. Incorrect. ACE inhibition describes lisinopril and enalapril — the drugs with the -pril suffix.

Note: Dental relevance of non-selective beta blockade: epinephrine in local anesthetic can produce unopposed alpha-mediated vasoconstriction with a rise in blood pressure and reflex bradycardia. Limit the dose, aspirate carefully, and monitor.

Permanent page for this question

Question 4

Which of her medications has been associated in the literature with the diffuse pulp chamber narrowing seen incidentally on her panoramic radiograph?

  1. Nitroglycerin
  2. Simvastatin
  3. Aspirin
  4. Carvedilol
Show answer and explanation

Correct answer: B. Simvastatin

  • A. Incorrect. Nitroglycerin is used acutely and intermittently and has no documented effect on pulpal tissue.
  • B. Correct. Several retrospective imaging studies have reported an association between long-term statin use and reduced pulp chamber volume, attributed to the pleiotropic effects of statins on osteoblastic and odontoblastic differentiation, including BMP-2 upregulation.
  • C. Incorrect. Low-dose aspirin affects platelet function, not dentinogenesis.
  • D. Incorrect. Beta blockers have no reported association with pulpal calcification.

Note: Flagged — this is a recognized board answer but the evidence is limited and consists mainly of retrospective radiographic studies. The far more common causes of pulp canal obliteration remain age, trauma, attrition, deep restorations, and orthodontic movement. Keep those first in your clinical differential.

Permanent page for this question

Practice patient cases Pharmacology study notes